Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Blood|June 3, 2006
Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantationPersis J Amrolia, Giada Muccioli-Casadei, Helen Huls, et al.
Nature Medicine|September 26, 2006
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individualsAnn M Leen, G Doug Myers, Uluhan Sili, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2014
Bioengineering T cells to target carbohydrate to treat opportunistic fungal infectionPappanaicken R Kumaresan, Pallavi R Manuri, Nathaniel D Albert, et al.
Scientific Reports|February 24, 2016
Genetic editing of HLA expression in hematopoietic stem cells to broaden their human applicationHiroki Torikai, Tiejuan Mi, Loren Gragert, et al.
Blood|April 27, 2012
A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCRHiroki Torikai, Andreas Reik, Pei-Qi Liu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 5, 2013
Sleeping beauty system to redirect T-cell specificity for human applicationsSourindra N Maiti, Helen Huls, Harjeet Singh, et al.
Human Gene Therapy|November 13, 2009
piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignanciesPallavi V Raja Manuri, Matthew H Wilson, Sourindra N Maiti, et al.
Blood|June 7, 2013
Toward eliminating HLA class I expression to generate universal cells from allogeneic donorsHiroki Torikai, Andreas Reik, Frank Soldner, et al.
Frontiers in Immunology|November 28, 2022
Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignanciesHarjeet Singh, Samer A Srour, Denái R Milton, et al.
The Journal of Clinical Investigation|August 3, 2016
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cellsPartow Kebriaei, Harjeet Singh, M Helen Huls, et al.
Pageof 6